Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merten Hommann

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 25, 2012
Intraoperative somatostatin receptor detection after peptide receptor radionuclide therapy with (177)Lu- and (90)Y-DOTATOC (tandem PRRNT) in a patient with a metastatic neuroendocrine tumorMila Todorović-Tirnanić, Daniel Kaemmerer, Vikas Prasad, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2009
Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CTVikas Prasad, Valentina Ambrosini, Merten Hommann, et al.
International Journal of Clinical and Experimental Pathology|December 14, 2012
Correlation of monoclonal and polyclonal somatostatin receptor 5 antibodies in pancreatic neuroendocrine tumorsDaniel Kaemmerer, Amelie Lupp, Luisa Peter, et al.
International Journal of Oncology|March 11, 2004
Proteomic profiling in microdissected hepatocellular carcinoma tissue using ProteinChip technologyChristian Melle, Roland Kaufmann, Merten Hommann, et al.
World Journal of Gastroenterology|December 10, 2009
Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic tumorDaniel Kaemmerer, Vikas Prasad, Wolfgang Daffner, et al.
Clinical & Experimental Metastasis|June 18, 2011
Localization of sporadic neuroendocrine tumors by gene expression analysis of their metastasesNicole Posorski, Daniel Kaemmerer, Guenther Ernst, et al.
Oncotarget|August 11, 2015
Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancyDaniel Kaemmerer, Tina Träger, Maike Hoffmeister, et al.
Clinical Nuclear Medicine|January 10, 2012
Radioguided surgery in neuroendocrine tumors using Ga-68-labeled somatostatin analogs: a pilot studyDaniel Kaemmerer, Vikas Prasad, Wolfgang Daffner, et al.
Annals of Surgery|October 8, 2020
Prior Resection of the Primary Tumor Prolongs Survival After Peptide Receptor Radionuclide Therapy of Advanced Neuroendocrine NeoplasmsDaniel Kaemmerer, Matthias Twrznik, Harshad R Kulkarni, et al.
International Journal of Clinical and Experimental Pathology|May 5, 2012
Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumorsDaniel Kaemmerer, Luisa Peter, Amelie Lupp, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 25, 2012
Intraoperative somatostatin receptor detection after peptide receptor radionuclide therapy with (177)Lu- and (90)Y-DOTATOC (tandem PRRNT) in a patient with a metastatic neuroendocrine tumorMila Todorović-Tirnanić, Daniel Kaemmerer, Vikas Prasad, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2009
Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CTVikas Prasad, Valentina Ambrosini, Merten Hommann, et al.
International Journal of Clinical and Experimental Pathology|December 14, 2012
Correlation of monoclonal and polyclonal somatostatin receptor 5 antibodies in pancreatic neuroendocrine tumorsDaniel Kaemmerer, Amelie Lupp, Luisa Peter, et al.
International Journal of Oncology|March 11, 2004
Proteomic profiling in microdissected hepatocellular carcinoma tissue using ProteinChip technologyChristian Melle, Roland Kaufmann, Merten Hommann, et al.
World Journal of Gastroenterology|December 10, 2009
Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic tumorDaniel Kaemmerer, Vikas Prasad, Wolfgang Daffner, et al.
Clinical & Experimental Metastasis|June 18, 2011
Localization of sporadic neuroendocrine tumors by gene expression analysis of their metastasesNicole Posorski, Daniel Kaemmerer, Guenther Ernst, et al.
Oncotarget|August 11, 2015
Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancyDaniel Kaemmerer, Tina Träger, Maike Hoffmeister, et al.
Clinical Nuclear Medicine|January 10, 2012
Radioguided surgery in neuroendocrine tumors using Ga-68-labeled somatostatin analogs: a pilot studyDaniel Kaemmerer, Vikas Prasad, Wolfgang Daffner, et al.
Annals of Surgery|October 8, 2020
Prior Resection of the Primary Tumor Prolongs Survival After Peptide Receptor Radionuclide Therapy of Advanced Neuroendocrine NeoplasmsDaniel Kaemmerer, Matthias Twrznik, Harshad R Kulkarni, et al.
International Journal of Clinical and Experimental Pathology|May 5, 2012
Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumorsDaniel Kaemmerer, Luisa Peter, Amelie Lupp, et al.
Pageof 4